Escitalopram is a selective serotonin reuptake inhibitor antidepressant approved by the Food and Drug Administration for the treatment of major depressive disorder and generalized anxiety disorder. A 34-year-old female patient with major depressive disorder developed amenorrhea and had a false-positive urine pregnancy test after initiation of escitalopram treatment. To our knowledge, no published case report of amenorrhea and false-positive urine pregnancy tests in women taking escitalopram exists. This case report suggests that women of child-bearing age should be carefully monitored for amenorrhea while they are on an antidepressant treatment regimen.
introduCtion
There have been a few case reports on selective serotonin reuptake inhibitor (SSRI)-induced hyperprolactinemia, [1] [2] [3] which may lead to secondary amenorrhea; however, to our knowledge, this is the first case in which a false-positive urine pregnancy test was observed following initiation of escitalopram treatment. This case report suggests that women of child-bearing age taking antidepressants should be closely monitored.
CAse rePort
Miss L is a 34-year-old Caucasian female with a history of premenstrual dysphoric disorder and panic disorder. She was started on citalo- 
